1 January 2025 false No description of principal activity Taxfiler 2024.6 true 07458115business:PrivateLimitedCompanyLtd2025-01-012025-12-31 074581152024-12-31 074581152025-01-012025-12-31 07458115business:AuditExemptWithAccountantsReport2025-01-012025-12-31 07458115business:FilletedAccounts2025-01-012025-12-31 074581152025-12-31 07458115business:Director12025-01-012025-12-31 07458115business:Director22025-01-012025-12-31 07458115business:RegisteredOffice2025-01-012025-12-31 074581152024-12-31 07458115core:WithinOneYear2025-12-31 07458115core:WithinOneYear2024-12-31 07458115core:AfterOneYear2025-12-31 07458115core:AfterOneYear2024-12-31 07458115core:ShareCapitalcore:PreviouslyStatedAmount2025-12-31 07458115core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 07458115core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-12-31 07458115core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 07458115core:PreviouslyStatedAmount2025-12-31 07458115core:PreviouslyStatedAmount2024-12-31 07458115business:SmallEntities2025-01-012025-12-31 07458115countries:EnglandWales2025-01-012025-12-31 07458115core:PlantMachinery2025-01-012025-12-31 07458115core:FurnitureFittings2025-01-012025-12-31 07458115core:ComputerEquipment2025-01-012025-12-31 07458115core:PlantMachinery2024-12-31 07458115core:FurnitureFittings2024-12-31 07458115core:ComputerEquipment2024-12-31 07458115core:PlantMachinery2025-12-31 07458115core:FurnitureFittings2025-12-31 07458115core:ComputerEquipment2025-12-31 07458115core:AfterOneYear2025-01-012025-12-31 07458115business:OrdinaryShareClass12025-01-012025-12-31 07458115business:OrdinaryShareClass12024-01-012024-12-31 07458115business:Director112025-01-012025-12-31 07458115business:Director112024-12-31 07458115business:Director112025-12-31 0745811512025-01-012025-12-31 074581152024-01-012024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 07458115 (England and Wales)
ENT CARE LTD Unaudited accounts for the year ended 31 December 2025
ENT CARE LTD Unaudited accounts Contents
Page
- 2 -
ENT CARE LTD Company Information for the year ended 31 December 2025
Directors
J Hamann P Hamann
Company Number
07458115 (England and Wales)
Registered Office
Spire Hospital Fordcombe Road Tunbridge Wells Kent TN3 0RD
Accountants
Adams O'Rourke Accountants Ltd 436 Woolton Road Liverpool L25 6JQ
- 3 -
ENT CARE LTD Statement of financial position as at 31 December 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
1,871 
2,544 
Current assets
Debtors
25,006 
28,609 
Cash at bank and in hand
276,865 
296,070 
301,871 
324,679 
Creditors: amounts falling due within one year
(80,790)
(119,468)
Net current assets
221,081 
205,211 
Total assets less current liabilities
222,952 
207,755 
Creditors: amounts falling due after more than one year
- 
(4,167)
Provisions for liabilities
Deferred tax
(467)
(483)
Net assets
222,485 
203,105 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
222,385 
203,005 
Shareholders' funds
222,485 
203,105 
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 16 September 2026 and were signed on its behalf by
J Hamann Director Company Registration No. 07458115
- 4 -
ENT CARE LTD Notes to the Accounts for the year ended 31 December 2025
1
Statutory information
ENT CARE LTD is a private company, limited by shares, registered in England and Wales, registration number 07458115. The registered office is Spire Hospital , Fordcombe Road, Tunbridge Wells, Kent, TN3 0RD.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
over 3 years straightline (4 years for Office Equipment)
Fixtures & fittings
over 4 years straightline
Computer equipment
over 3 years straightline
Going concern
The company is expected to cease carrying on its private ENT practice during October 2026. The directors are considering whether to retain the company for other activities or to wind it up, and had not reached a decision at the date on which these accounts were approved. That decision awaits further advice on matters personal to the directors. The company has no external borrowings other than the bank loan disclosed in note 9. Its liabilities consist principally of corporation tax and its assets principally of cash, and the directors are satisfied that it is able to meet its liabilities as they fall due. The accounts have accordingly been prepared on the going concern basis. Were the directors subsequently to resolve to wind the company up, that basis would cease to be appropriate. Because the company's assets consist principally of cash and amounts receivable, the directors do not expect the effect on the amounts recognised in these accounts to be material.
- 5 -
ENT CARE LTD Notes to the Accounts for the year ended 31 December 2025
4
Tangible fixed assets
Plant & machinery 
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At 1 January 2025
6,991 
959 
22,750 
30,700 
Additions
299 
- 
1,599 
1,898 
At 31 December 2025
7,290 
959 
24,349 
32,598 
Depreciation
At 1 January 2025
6,677 
959 
20,520 
28,156 
Charge for the year
262 
- 
2,309 
2,571 
At 31 December 2025
6,939 
959 
22,829 
30,727 
Net book value
At 31 December 2025
351 
- 
1,520 
1,871 
At 31 December 2024
314 
- 
2,230 
2,544 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Trade debtors
18,907 
28,072 
Accrued income and prepayments
510 
537 
Other debtors
5,589 
- 
25,006 
28,609 
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Bank loans and overdrafts
4,167 
10,000 
Trade creditors
612 
198 
Taxes and social security
85,747 
65,102 
Loans from directors
(23,063)
43,588 
Accruals
13,327 
580 
80,790 
119,468 
7
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Bank loans
- 
4,167 
£50k Bounce Back loan
8
Share capital
2025 
2024 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
- 6 -
ENT CARE LTD Notes to the Accounts for the year ended 31 December 2025
9
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Loan 1
- 
252,930 
229,867 
23,063 
- 
252,930 
229,867 
23,063 
Interest free and repayable on demand (joint account)
10
Transactions with related parties
£23,063 was owed by the director joint account as at 31 December 2025.
11
Controlling party
The company is controlled by both directors who own 100% of the share capital.
12
Post balance sheet events
The company expects to cease carrying on its private ENT practice during October 2026. The directors had not, at the date of approval of these accounts, resolved whether the company should thereafter be retained for other activities or wound up. On 15 September 2026 the directors declared an interim dividend of £23,063, which was credited to the directors' loan account on 16 September 2026 and discharged in full the balance outstanding at 31 December 2025 disclosed in note 12. None of these events are reflected in the amounts recognised in these accounts.
13
Average number of employees
During the year the average number of employees was 3 (2024: 2).
- 7 -